Posted Jun. 20, 2013 at 3:18 p.m.

Premium Lock GSK teams with French VC firm in $58M fund targeting rare diseases

Published: 2013-06-20 15:18:31
Updated: 2013-06-20 15:18:31


Kurma Life Science Partners says its new fund is the first one focused on financing and developing new drugs for so called "orphan" diseases....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders